Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 33, 2004 - Issue 1
41
Views
4
CrossRef citations to date
0
Altmetric
Original

Expression of Y7 Cross‐Reactive Idiotope on Human IgM Molecules

, , , , , , & show all
Pages 1-14 | Published online: 26 Aug 2009
 

Abstract

In this paper we report data regarding the IgM Y7 cross‐reactive idiotope (CRIo) obtained by analysis of: 1) its V‐gene subgroup dependance, 2) the frequency of its expression on human monoclonal IgMs and IgM molecules from normal and pathological sera. Furthermore, comparison of epitopic repertoire and nature of binding of human monoclonal IgMs expressing Y7 CRIo was performed to confirm the natural antibody properties of these molecules. IgM isolated from sera of patient DJ (IgM DJ) which expresses the Y7 idiotope has been classified to VH3/VL2 subgroup. From ten IgMs tested only IgM from patient RD (IgM RD) has been shown to express Y7 idiotope. Y7+ human IgMs bound to ssDNA, lactic acid bacteria, mouse laminin, porcine thyroglobulin and mouse IgG. Higher percentage of the expression of Y7 CRIo was detected in the sera of patients suffering from autoimmune diseases such as lupus, rheumatoid arthritis and psoriasis vulgaris as well as in patients suffering from chronic infections of the lower urinary tract. Antigen binding repertoire and properties of Y7+ monoclonal IgM, frequency of Y7 expression on monoclonal IgMs and its concentration in normal and pathological sera indicate the important biological role of this CRIo within the immune system.

ALS:=

amyotrophic lateral sclerosis

BC:=

breast cancer

CRI:=

cross‐reactive idiotype

CRIo:=

cross‐reactive idiotope

MAb:=

monoclonal antibody

NHS:=

normal human sera

PC:=

phosphorylcholine

PV:=

psoriasis vulgaris

RA:=

rheumatoid arthritis

RF:=

rheumatoid factor

SLE:=

systemic lupus erithematosus

ssDNA:=

single strand DNA

UI:=

urinary infections

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.